The latest study by Fact.MR expects the global market for pharyngitis to experience sluggish growth. Towards 2026 end, the global market for pharyngitis is projected to bring in US$ 1,679.0 million revenue. Pharyngitis is the most common manifestation of infection. Antibiotics are given in case of a sore throat, however, they provide very modest benefit. It is still unclear which antibiotic is the best for the treatment of a sore throat. Hence, various research and trials are being conducted to find most effective antibiotic.